Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings

(2013) David B. Rein et al.   ANNALS OF INTERNAL MEDICINE

New Protease Inhibitors for the Treatment of Chronic Hepatitis C

(2013) Shan Liu et al.   ANNALS OF INTERNAL MEDICINE

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

(2013) Rebecca L. Morgan et al.   ANNALS OF INTERNAL MEDICINE

Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients With Chronic Hepatitis C Virus Genotype 1 Infection—A Randomized Trial

(2013) Fred Poordad et al.   GASTROENTEROLOGY

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

(2013) Christophe Hézode et al.   JOURNAL OF HEPATOLOGY

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

(2013) Eric Lawitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States

(2013) Shan Liu et al.   PLoS One

Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C

(2012) Calogero Cammà et al.   HEPATOLOGY

Informed deferral: A moral requirement for entry into the hepatitis C virus treatment warehouse

(2012) Andrew Aronsohn et al.   HEPATOLOGY

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

(2011) Marc G. Ghany et al.   HEPATOLOGY

Impact of a sustained virological response on the long-term outcome of hepatitis C

(2011) Alfredo Alberti   LIVER INTERNATIONAL

Health Technology Assessment Implementation

(2011) Daniel Callahan   MEDICAL DECISION MAKING

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients

(2011) Shan Liu et al.   PLoS One

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

(2010) C. CAMMÀ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Liver Match, a prospective observational cohort study on liver transplantation in Italy: Study design and current practice of donor–recipient matching

(2010) Mario Angelico et al.   DIGESTIVE AND LIVER DISEASE

Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study

(2010) Savino Bruno et al.   HEPATOLOGY

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis

(2010) Ana-Carolina Cardoso et al.   JOURNAL OF HEPATOLOGY

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus

(2009) Amit G. Singal et al.   Clinical Gastroenterology and Hepatology

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

(2009) Takeru Shiroiwa et al.   HEALTH ECONOMICS